Something to do with the following (using the list of milestones which they published in December 2022):
Given they have recently entered into an agreement to manufacture Psilosybin for commercial use and for their trials, I am going to assume that this news will be good news. It's been a while since we have seen a TH - not used to having to wait.....nothing else for it but to enjoy a long weekend (for Victorians at least) and try not to think about it too much.
Also - based on the 10 days per milestone (<- please note this is not an official company target!!), their next milestone was not due until 13 March - so they are getting in early
IHL Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
